Trendlines receives FDA regulatory clearance for meniscus repair system

-A +A

SINGAPORE (June 19): Trendlines Group announced that its portfolio company, Arcuro Medical, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall meniscus repair system.

This comes after Arcuro completed an extensive and successful series of pre-clinical studies in the US and Israel.

Superball is an all-suture meniscus repair system that preserves knee functionality that is secure, reliable, and effective.

Currently, practitioners would seek to avoid removal of...(click on link for full story on theedgesingapore.com)